Roux F X, Panthier J N, Tanghe Y M, Gallina P, Oswald A M, Mérienne L, Cioloca C
Service de Neurochirurgie, Centre Hospitalier Sainte Anne, Paris.
Neurochirurgie. 1991;37(2):106-10.
The Terson syndrome was described in the early 1900's as the association of an intra-vitreous humor bleeding and a subarachnoidal hemorrhage (SAH). The high jeopardy of blindness of such a syndrome emphasizes the importance of evaluating as soon as possible the presence of blood in the posterior chamber of patients presenting with a SAH. 250 patients admitted in the Neurosurgical Department of Ste Anne Hospital with a SAH were evaluated between January 1984 and February 1990. 26 had an intra-ocular hemorrhage (10.5%). In those cases the mortality rate was not increased (15.4%) but the morbidity rate was higher (42%). Concerning the intra-ocular bleeding, 4 patients underwent a vitrectomy (2 had a complementary photocoagulation). Only one patient had a visual sequela (partial decrease of visual acuity). These data emphasize the visual risk which has to be considered; a specific treatment (vitrectomy and/or photocoagulation) must be performed as quickly as possible so as to save the vision. In some particular instances, the ophthalmological treatment might even be necessary before the intracranial procedure itself.
特森综合征在20世纪初被描述为玻璃体内出血与蛛网膜下腔出血(SAH)并存。该综合征导致失明的高风险凸显了对SAH患者尽快评估后房内是否存在血液的重要性。1984年1月至1990年2月期间,对圣安妮医院神经外科收治的250例SAH患者进行了评估。其中26例发生眼内出血(10.5%)。在这些病例中,死亡率未升高(15.4%),但发病率较高(42%)。关于眼内出血,4例患者接受了玻璃体切除术(2例辅助进行了光凝治疗)。只有1例患者有视觉后遗症(视力部分下降)。这些数据强调了必须考虑的视觉风险;必须尽快进行特定治疗(玻璃体切除术和/或光凝治疗)以挽救视力。在某些特殊情况下,甚至可能在颅内手术之前就需要进行眼科治疗。